In Sézary Syndrome (SS), an aggressive, rare form of cutaneous T-cell lymphomas (CTCL), circulating CD4+ T-cells show increased expression of PLS3, TWIST1 and GATA6 compared to normal CD4+ T-cells [96, 97]. This evidence concerns the gene GATA6 and primary cutaneous T-cell non-Hodgkin lymphoma.